Kamiren

Doxazosin, the active ingredient in Kamiren, is a Alpha‑1 adrenergic blocker presented as an oral tablet for oral use. It is used to treat hypertension and benign prostatic hyperplasia in adult patients. GNH USA supplies Kamiren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Doxazosin acts on the alpha‑1 adrenergic receptor pathway to manage cardiovascular and urological conditions. - Hypertension: lowers systemic blood pressure by causing vasodilation and reducing peripheral resistance. - Benign prostatic hyperplasia (BPH): relaxes smooth muscle in the prostate and bladder neck, improving urinary flow and reducing symptoms.

Doxazosin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nasal congestion - Peripheral edema - Nausea

Serious or Rare Side Effects: - Severe hypotension or syncope - Priapism - Anaphylactic reaction - Acute liver injury (rare) - Heart failure exacerbation - Sudden cardiac arrest

Before initiating therapy, consider the following safety measures. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Renal and hepatic function: assess organ status, especially in patients with impairment. - Orthostatic hypotension: advise patients to rise slowly from sitting or lying positions. - Concomitant antihypertensives: adjust doses to prevent additive blood‑pressure lowering effects. - Prostate surgery: use with caution as rapid smooth‑muscle relaxation may affect intra‑operative bleeding. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) – may increase plasma levels. - Other antihypertensives (e.g., ACE inhibitors, ARBs) – risk of additive hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) – can cause severe drops in blood pressure.

Moderate Interactions (Monitor Closely):\n- Diuretics – may enhance orthostatic hypotension; monitor electrolytes. - NSAIDs – may blunt antihypertensive effect. - Lithium – possible increase in lithium levels; check serum concentrations. - Beta‑blockers – additive heart‑rate slowing; observe for bradycardia. - Alcohol – may potentiate dizziness and hypotension.